NF-κB p105 is a target of IκB kinases and controls signal induction of Bcl-3-p50 complexes

EMBO Journal

Volumn 18, Issue 17, 1999, Pages 4766-4778

  Heissmeyer, Vigo ^a   Krappmann, Daniel ^a   Wulczyn, F Gregory ^a,b   Scheidereit, Claus ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Kinases; Oncogene; Proteasome; Transcription activation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR; INTERLEUKIN 1BETA; PHORBOL ESTER; PHOSPHOTRANSFERASE; PROTEASOME; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CHUK PROTEIN, HUMAN; I KAPPA B; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN PRECURSOR; PROTEIN SERINE THREONINE KINASE; PROTO ONCOGENE PROTEIN BCL 3; PROTO-ONCOGENE PROTEIN BCL-3; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CYTOPLASM; HUMAN; HUMAN CELL; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CELL LINE; DIMERIZATION; GENETIC TRANSFECTION; HELA CELL; METABOLISM; PHOSPHORYLATION; PLASMID; TIME;

CELL LINE; DIMERIZATION; HELA CELLS; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; MODELS, BIOLOGICAL; MODELS, GENETIC; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PHOSPHORYLATION; PLASMIDS; PROTEIN PRECURSORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033199348     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.17.4766     Document Type: Article

References (78)

1. Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A. and Ben Neriah, Y. (1995) Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA, 92, 10599-105603.
2. Baeuerle, P.A. and Baltimore, D. (1996) NF-κB: ten years after. Cell, 87, 13-20.
3. Baeuerle, P.A. and Henkel, T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol., 12, 141-179.
4. Baldi, L., Brown, K., Franzoso, G. and Siebenlist, U. (1996) Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of IκB-α. J. Biol. Chem., 271, 376-379.
5. Baldwin, A.S.,Jr (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649-683.
6. Barnes, P.J. and Karin, M. (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336, 1066-1071.
7. Belich, M.P., Salmeron, A., Johnston, L.H. and Ley, S.C. (1999) TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105. Nature, 397, 363-368.
8. Betts, J.C. and Nabel, G.J. (1996) Differential regulation of NF-κB2 (p100) processing and control by amino-terminal sequences. Mol. Cell. Biol., 16, 6363-6371.
9. Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Brown, K. and Siebenlist, U. (1993) The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 72, 729-739.
10. Brockman, J.A., Scherer, D.C., McKinsey, T.A., Hall, S.M., Qi, X., Lee, W.Y. and Ballard, D.W. (1995) Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol., 15, 2809-2818.
11. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G. and Siebenlist, U. (1995) Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science, 267, 1485-1488.
12. Bundy, D.L. and McKeithan, T.W. (1997) Diverse effects of BCL3 phosphorylation on its modulation of NF-κB p52 homodimer binding to DNA. J. Biol. Chem., 272, 33132-33139.
13. Caamano, J.H., Perez, P., Lira, S.A. and Bravo, R. (1996) Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimers in vivo. Mol. Cell. Biol., 16, 1342-1348.
14. Chen, Z., Hagler, J., Palombella, V.J., Melandri, F., Scherer, D., Ballard, D. and Maniatis, T. (1995) Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev., 9, 1586-1597.
15. Cohen, L., Henzel, W.J. and Baeuerle, P.A. (1998) IKAP is a scaffold protein of the IκB kinase complex. Nature, 395, 292-296.
16. Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F.G., Scheidereit, C. and Leutz, A. (1999) The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators. Oncogene, 18, 3316-3323.
17. DiDonato, J., Mercurio, F., Rosette, C., Wu Li, J., Suyang, H., Ghosh, S. and Karin, M. (1996) Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol., 16, 1295-1304.
18. DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E. and Karin, M. (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature, 388, 548-554.
19. Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11, 1475-1489.
20. Donald, R., Ballard, D.W. and Hawiger, J. (1995) Proteolytic processing of NF-κB/IκB in human monocytes. ATP-dependent induction by pro-inflammatory mediators. J. Biol. Chem., 270, 9-12.
21. Drier, E.A., Huang, L.H. and Steward, R. (1999) Nuclear import of the Drosophila Rel protein Dorsal is regulated by phosphorylation. Genes Dev., 13, 556-568.
22. Franzoso, G., Bours, V., Park, S., Tomita Yamaguchi, M., Kelly, K. and Siebenlist, U. (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature, 359, 339-342.
23. Franzoso, G. et al. (1997) Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture and germinal center reactions. Immunity, 6, 479-490.
24. Fujita, T., Nolan, G.P., Liou, H.C., Scott, M.L. and Baltimore, D. (1993) The candidate proto-oncogene Bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev., 7, 1354-1363.
25. Hager, D.A. and Burgess, R.R. (1980) Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase and other enzymes. Anal. Biochem., 109, 76-86.
26. Harhaj, E.W., Maggirwar, S.B. and Sun, S.C. (1996) Inhibition of p105 processing by NF-κB proteins in transiently transfected cells. Oncogene, 12, 2385-2392.
27. Hatada, E.N., Naumann, M. and Scheidereit, C. (1993) Common structural constituents confer IκB activity to NF-κB p105 and IκB/MAD-3. EMBO J., 12, 2781-2788.
28. Hirano, F., Tanaka, H., Hirano, Y, Hiramoto, M., Handa, H., Makino, I. and Scheidereit, C. (1998) Functional interference of Sp1 and NF-κB through the same DNA binding site. Mol. Cell. Biol., 18, 1266-1274.
29. Ishikawa, H., Ryseck, R.P. and Bravo, R. (1996) Characterization of ES cells deficient for the p105 precursor (NF-κB1): role of p50 NLS. Oncogene, 13, 255-263.
30. Israel, A. (1995) A role for phosphorylation and degradation in the control of NF-κB activity. Trends Genet., 11, 203-205.
31. Krappmann, D., Wulczyn, F.G. and Scheidereit, C. (1996) Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo. EMBO J., 15, 6716-6726.
32. Lee, F.S., Peters, R.T., Dang, L.C. and Maniatis, T. (1998) MEKK1 activates both IκB kinase α and IκB kinase β. Proc. Natl Acad. Sci. USA, 95, 9319-9324.
33. Li, J., Peet, G.W., Pullen, S.S., Schembri King, J., Warren, T.C., Marcu, K.B., Kehry, M.R., Barton, R. and Jakes, S. (1998) Recombinant IκB kinases α and β are direct kinases of IκBα. J. Biol. Chem., 273, 30736-30741.
34. Lin, L. and Ghosh, S. (1996) A glycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit. Mol. Cell. Biol., 16, 2248-2254.
35. Lin, L., DeMartino, G.N. and Greene, W.C. (1998) Cotranslational biogenesis of NF-κB p50 by the 26S proteasome. Cell, 92, 819-828.
36. Lin, X., Cunningham, E.T.J., Mu, Y., Geleziunas, R. and Greene, W.C. (1999) The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity, 10, 271-280.
37. MacKichan, M.L., Logeat, F. and Israel, A. (1996) Phosphorylation of p105 PEST sequence via a redox-insensitive pathway up-regulates processing of p50 NF-κB. J. Biol. Chem., 271, 6084-6091.
38. Malinin, N.L., Boldin, M.P., Kovalenko, A.V. and Wallach, D. (1997) MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature, 385, 540-544.
39. Maniatis, T. (1997) Catalysis by a multiprotein IκB kinase complex. Science, 278, 818-819.
40. May, M.J. and Ghosh, S. (1997) Rel/NF-κB and IκB proteins: an overview. Semin. Cancer Biol., 8, 63-73.
41. Mellits, K.H., Hay, R.T. and Goodbourn, S. (1993) Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res., 21, 5059-5066.
42. Mercurio, F., DiDonato, J.A., Rosette, C. and Karin, M. (1993) p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev., 7, 705-718.
43. Mercurio, F. et al. (1997) IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science, 278, 860-866.
44. Mercurio, F. et al. (1999) IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol., 19, 1526-1538.
45. Meyer, R. et al. (1991) Cloning of the DNA-binding subunit of human nuclear factor κB: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor α. Proc. Natl Acad. Sci. USA, 88, 966-970.
46. Naumann, M. and Scheidereit, C. (1994) Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J., 13, 4597-4607.
47. Naumann, M., Nieters, A., Hatada, E.N. and Scheidereit, C. (1993a) NF-κB precursor p100 inhibits nuclear translocation and DNA binding of NF-κB/rel-factors. Oncogene, 8, 2275-2281.
48. Naumann, M., Wulczyn, F.G. and Scheidereit, C. (1993b) The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB. EMBO J., 12, 213-222.
49. Neumann, M., Tsapos, K., Scheppler, J.A., Ross, J. and Franza, B.R.,Jr (1992) Identification of complex formation between two intracellular tyrosine kinase substrates: human c-Rel and the p105 precursor of p50 NF-κB. Oncogene, 7, 2095-2104.
50. Nolan, G.P., Fujita, T., Bhatia, K., Huppi, C., Liou, H.C., Scott, M.L. and Baltimore, D. (1993) The Bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol. Cell. Biol., 13, 3557-3566.
51. Palombella, V.J., Rando, O.J., Goldberg, A.L. and Maniatis, T. (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell, 78, 773-785.
52. Pan, J. and McEver, R.P. (1995) Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-κB/Rel family. J. Biol. Chem., 270, 23077-23083.
53. Patriotis, C., Makris, A., Chernoff, J. and Tsichlis, P.N. (1994) Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase. Proc. Natl Acad. Sci. USA, 91, 9755-9759.
54. Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z. and Rothe, M. (1997) Identification and characterization of an IκB kinase. Cell, 90, 373-383.
55. Rice, N.R., MacKichan, M.L. and Israel, A. (1992) The precursor of NF-κB p50 has IκB-like functions. Cell, 71, 243-253.
56. Rodriguez, M.S., Wright, J., Thompson, J., Thomas, D., Baleux, F., Virelizier, J.L., Hay, R.T. and Arenzana Seisdedos, F. (1996) Identification of lysine residues required for signal-induced ubiquitination and degradation of IκB-α in vivo. Oncogene, 12, 2425-2435.
57. Roff, M., Thompson, J., Rodriguez, M.S., Jacque, J.M., Baleux, F., Arenzana Seisdedos, F. and Hay, R.T. (1996) Role of IκBα ubiquitination in signal-induced activation of NFκB in vivo. J. Biol. Chem., 271, 7844-7850.
58. Rothwarf, D.M., Zandi, E., Natoli, G. and Karin, M. (1998) IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature, 395, 297-300.
59. Salmeron, A., Ahmad, T.B., Carlile, G.W., Pappin, D., Narsimhan, R.P. and Ley,S.C. (1996) Activation of MEK-1 and SEK-1 by Tpl-2 protooncoprotein, a novel MAP kinase kinase kinase. EMBO J., 15, 817-826.
60. Scherer, D.C., Brockman, J.A., Chen, Z., Maniatis, T. and Ballard, D.W. (1995) Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl Acad. Sci. USA, 92, 11259-11263.
61. Schwarz, E.M., Krimpenfort, P., Berns, A. and Verma, I.M. (1997) Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev., 11, 187-197.
62. Sears, C., Olesen, J., Rubin, D., Finley, D. and Maniatis, T. (1998) NF-κB p105 processing via the ubiquitin-proteasome pathway. J. Biol. Chem., 273, 1409-1419.
63. Sha, W.C., Liou, H.C., Tuomanen, E.I. and Baltimore, D. (1995) Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell, 80, 321-330.
64. Spencer, E., Jiang, J. and Chen, Z.J. (1999) Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP. Genes Dev., 13, 284-294.
65. Stancovski, I. and Baltimore, D. (1997) NF-κB activation: the IκB kinase revealed? Cell, 91, 299-302.
66. Traenckner, E.B., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S. and Baeuerle, P.A. (1995) Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli. EMBO J., 14, 2876-2883.
67. Tsatsanis, C., Patriotis, C. and Tsichlis, P.N. (1998) Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-κB. Oncogene, 17, 2609-2618.
68. Verma, J.M., Stevenson, J.K., Schwarz, E.M., Van Antwerp, D. and Miyamoto, S. (1995) Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev., 9, 2723-2735.
69. Watanabe, N., Iwamura, T., Shinoda, T. and Fujita, T. (1997) Regulation of NFκB1 proteins by the candidate oncoprotein BCL-3: generation of NF-κB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation. EMBO J., 16, 3609-3620.
70. Whiteside, S.T., Ernst, M.K., LeBail, O., Laurent Winter, C., Rice, N. and Israel, A. (1995) N- and C-terminal sequences control degradation of MAD3/IκBα in response to inducers of NF-αB activity. Mol. Cell. Biol., 15, 5339-5345.
71. Winston, J.T., Strack, P., Beer Romero, P., Chu, C.Y., Elledge, S.J. and Harper, J.W. (1999) The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev., 13, 270-283.
72. Woronicz, J.D., Gao, X., Cao, Z., Rothe, M. and Goeddel, D.V. (1997) IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science, 278, 866-869.
73. Wulczyn, F.G., Naumann, M. and Scheidereit, C. (1992) Candidate protooncogene Bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature, 358, 597-599.
74. Wulczyn, F.G., Krappmann, D. and Scheidereit, C. (1996) The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation. J. Mol. Med., 74, 749-769.
75. Wulczyn, F.G., Krappmann, D. and Scheidereit, C. (1998) Signal-dependent degradation of IκBα is mediated by an inducible destruction box that can be transferred to NF-κB, Bcl-3 or p53. Nucleic Acids Res., 26, 1724-1730.
76. Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S.T., Weil, R., Agou, F., Kirk, H.E., Kay, R.J. and Israel, A. (1998) Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell, 93, 1231-1240.
77. Yaron, A. et al. (1998) Identification of the receptor component of the IκBα-ubiquitin ligase. Nature, 396, 590-594.
78. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M. and Karin, M. (1997) The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell, 91, 243-252.